QUANTERIX CORP (QTRX) Stock News

USA - NASDAQ:QTRX - US74766Q1013 - Common Stock

5.545 USD

-0.04 (-0.63%)

Last: 9/19/2025, 10:22:08 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

QTRX Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Quanterix Corporation

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

a month ago - By: Zacks Investment Research

Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)

a month ago - By: Quanterix Corporation

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

a month ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

a month ago - By: Benzinga

Earnings Preview: Quanterix

a month ago - By: Zacks Investment Research - Mentions: CAPR

Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates

a month ago - By: Quanterix Corporation

Quanterix Releases Financial Results for the Second Quarter of 2025

2 months ago - By: Quanterix Corporation

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

2 months ago - By: Quanterix Corporation

Quanterix Announces Cooperation Agreement with Kent Lake Capital

2 months ago - By: Quanterix Corporation

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

2 months ago - By: Quanterix Corporation

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Quanterix Corporation

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

3 months ago - By: Quanterix Corporation

Quanterix Expands Reach with IVD and Large Reference Labs

4 months ago - By: Quanterix Corporation

Quanterix to Present at Goldman Sachs Global Healthcare Conference

4 months ago - By: Kent Lake PR LLC - Mentions: AKYA

News Image

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

4 months ago - By: Zacks Investment Research - Mentions: MDT

Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

4 months ago - By: Quanterix Corporation

Quanterix Releases Financial Results for the First Quarter of 2025

4 months ago - By: Zacks Investment Research - Mentions: PAHC

Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates

5 months ago - By: Quanterix Corporation

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

5 months ago - By: Kent Lake PR LLC

Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders

5 months ago - By: Quanterix Corporation - Mentions: AKYA

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

5 months ago - By: Halper Sadeh LLC - Mentions: BRDG AKYA CKPT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders

5 months ago - By: Kent Lake PR LLC

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

6 months ago - By: Kent Lake PR LLC

Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya

6 months ago - By: Quanterix Corporation

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

6 months ago - By: Quanterix Corporation

Quanterix Releases Financial Results for the Fourth Quarter of 2024

6 months ago - By: Kent Lake PR LLC

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call